Omburtamab, an anti-CD276 (also known as B7-H3) monoclonal antibody, targets the B7/CD28 family protein CD276, prevalent in solid human tumors. This binding capability positions omburtamab as a potential research tool in various cancer studies [1] [2].
CAS Number:
[1895083-75-6]
* VAT and and shipping costs not included. Errors and price changes excepted
